drugset / Trial / NCT02410759

Carbetocin Versus Ergometrine in the Management of Atonic Post Partum Haemorrhage (PPH) in Women Delivered Vaginally

NCT02410759

Phase 3 Unknown 200 enrolled Cairo University
RandomizedParallel-groupDouble-blindTreatment

Summary

200 women will be randomly divided into 2 equal groups using computer generated random numbers. Group 1 will receive Carbetocin 100 µgm (Pabal® Ferring, UK) and group 2 will receive ergometrine 0.5mg (methergin®, Novartis, Switzerland).

Timeline

Start
2015-04
Primary completion
2017-03
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Carbetocin Peptide 100 ug Intramuscular
Comparator ergometrine Unknown 0.5 mg Intramuscular

Indications

No indication recorded.